ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 170 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $211,919 | +0.6% | 8,841 | +32.3% | 0.00% | – |
| Q4 2023 | $210,652 | -0.6% | 6,681 | -24.4% | 0.00% | – |
| Q1 2023 | $211,919 | -14.5% | 8,841 | -47.1% | 0.00% | -100.0% |
| Q3 2022 | $248,000 | -5.7% | 16,711 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $263,000 | 0.0% | 16,711 | +71.0% | 0.00% | 0.0% |
| Q1 2022 | $263,000 | -27.3% | 9,771 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $362,000 | -26.3% | 9,771 | -5.0% | 0.00% | 0.0% |
| Q3 2021 | $491,000 | +43.6% | 10,280 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $342,000 | -9.0% | 10,120 | +11.2% | 0.00% | 0.0% |
| Q1 2021 | $376,000 | -8.5% | 9,103 | -3.9% | 0.00% | 0.0% |
| Q4 2020 | $411,000 | +13.2% | 9,473 | +11.9% | 0.00% | 0.0% |
| Q3 2020 | $363,000 | +4.0% | 8,463 | +13.2% | 0.00% | 0.0% |
| Q2 2020 | $349,000 | – | 7,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |